Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Writers are racing each other to find the most alarming words to describe the party’s predicament — “leaderless, rudderless ...

The Lexus GX line falls near the upper middle of the Japanese automaker's range of SUV offerings. Here's are some things you ...

Job cuts cascaded through the federal government on Thursday after its human resources division advised agencies to terminate ...

Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio, today announced that the U.S. Food and Drug Administration (FDA) has approved Evolyssetm Form and ...

Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ETCompany ParticipantsWill McDowell - Vice President ...

In fact, many argue that even accounting for these factors, rice prices in retail should not exceed P49 ... This form of deception not only compromises driver welfare but also underscores a systemic ...

FirstService Corporation ( NASDAQ: FSV) Q4 2024 Earnings Conference Call February 5, 2025 11:00 AM ET Scott Patterson - Chief Executive Officer Jeremy Rakusin - Chief Financial Officer ...

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolled SAN FRANCISCO and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., ...

Trina Solar alleges infringement of two invention patents for the photovoltaic module products manufactured and sold by Canadian Solar: Patent 1 (ZL201710975923.2) for "solar cell modules" with a ...